Targeting apoptosis in prostate cancer: Focus on caspases and inhibitors of apoptosis proteins

BJU International, Supplement

Volumn 96, Issue 2, 2005, Pages 30-34

  Watson, R William G ^a   Fitzpatrick, John M ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Androgen independent prostate cancer; Anti apoptotic caspase regulators; Apoptosis; Inhibitors of apoptosis proteins; Prostate cancer

Indexed keywords

ANDROGEN; ANTISENSE OLIGONUCLEOTIDE; CASPASE; CASPASE INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN; MALEIC ACID DIETHYL ESTER;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONFERENCE PAPER; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; CASPASES; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS;

EID: 29944442302     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05944.x     Document Type: Conference Paper

References (36)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57
2. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251-4
3. Kerr JF, Winterford CM, Harmon BV. Apoptosis: Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26
4. Cohen JJ. Apoptosis. Immunol Today 1993; 14: 126-30
5. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J 1992; 6: 2450-5
6. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865-75
7. van Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996; 24: 131-9
8. Denmeade SR, Lin XS, Isaacs JT. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996; 28: 251-65
9. Berges RR, Vukanovic J, Epstein JI et al. Implication of the cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res 1995; 1: 473-80
10. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34-45
11. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts. Cell 1995; 82: 349-52
12. Stennicke HR, Salvesen GS. Properties of the caspases. Biochim Biophys Acta 1998; 1387: 17-31
13. Salvesen GS. Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 2002; 9: 3-5
14. Clem RJ, Duckett CS. The iap genes. Unique arbitrators of cell death. Trends Cell Biol 1997; 7: 337-45
15. Zhivotovsky B, Hanson KP, Orrenius S. Back to the future: the role of cytochrome c in cell death. Cell Death Differ 1998; 5: 459-60
16. Krajewska M, Wang HG, Krajewski S et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 1997; 57: 1605-13
17. O'Neill AJ, Boran SA, O'Keane C et al. Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma. Prostate 2001; 47; 183-8
18. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001; 61: 1227-32
19. Srikanth S, Kraft AS. Inhibition of caspases by cytokine response modifier A blocks androgen ablation-mediated prostate cancer cell death in vivo. Cancer Res 1998; 58: 834-9
20. Coffey RNT, Watson RWG, Hegarty PK et al. Priming prostate carcinoma cells for increased apoptosis is associated with upregulation of the caspases. Cancer 2001; 92: 2297-308
21. McEleny KR, Watson RWG, Fitzpatrick JM. Defining a role for the inhibitors of apoptosis proteins in prostate cancer. Prostate Cancer Prostatic Dis 2001; 4: 28-32
22. Biros I, Forrest S. Spinal muscular atrophy: untangling the knot? J Med Genet 1999; 36: 1-8
23. Iannaccone ST. Spinal muscular atrophy. Semin Neurol 1998; 18: 19-26
24. Roy N, Mahadevan MS, McLean et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80: 167-78
25. Liston P, Roy N, Tamai K et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379: 349-53
26. Chu Z-L, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-κB control. Proc Natl Acad Sci USA 1997; 94: 10057-62
27. Lee RT, Collins T. Nuclear factor-κB and cell survival: IAPs call for support. Circ Res 2001; 88: 262-4
28. Manji GA, Hozak RR, LaCount DJ, Friesen PD. Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor P35 to prevent programmed cell death. J Virol 1997; 71: 4509-16
29. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. Nuclear factor (NF) -κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumour necrosis factor α-induced apoptosis. J Exp Med 1998; 188: 211-6
30. WAF1 and IAP gene family ILP. Oncogene 1998; 17: 931-9
31. Tamm I, Wang Y, Sausville E et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315-20
32. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914-25
33. Deveraux QL, Roy N, Stennicke HR et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1997; 17: 2215-23
34. Krajewska M, Krajewski S, Banares S et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003; 9: 4914-25
35. McEleny KR, Watson RWG, O'Neill A, Coffey RN, Fitzpatrick JM. The inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 2002; 51: 131-40
36. McEleny KR, Coffey R, Morrissey C et al. An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis. Prostate 2004; 59: 419-25